tiprankstipranks
Advertisement
Advertisement
Myriad Genetics price target lowered to $6 from $8 at UBS
PremiumThe FlyMyriad Genetics price target lowered to $6 from $8 at UBS
1M ago
Myriad Genetics price target lowered to $6 from $6.50 at Wells Fargo
Premium
The Fly
Myriad Genetics price target lowered to $6 from $6.50 at Wells Fargo
1M ago
Execution and Reimbursement Risks Undermine Myriad Genetics’ Growth Outlook, Justifying Sell Rating
Premium
Ratings
Execution and Reimbursement Risks Undermine Myriad Genetics’ Growth Outlook, Justifying Sell Rating
1M ago
Is MYGN a Buy, Before Earnings?
PremiumPre-EarningsIs MYGN a Buy, Before Earnings?
1M ago
Myriad announce publication of validation of FirstGene Multiple Prenatal Screen
Premium
The Fly
Myriad announce publication of validation of FirstGene Multiple Prenatal Screen
1M ago
Myriad Genetics management to meet with BTIG
Premium
The Fly
Myriad Genetics management to meet with BTIG
2M ago
Myriad Genetics management to meet virtually with Craig-Hallum
PremiumThe FlyMyriad Genetics management to meet virtually with Craig-Hallum
4M ago
Myriad Genetics price target lowered to $8.50 from $9 at Piper Sandler
Premium
The Fly
Myriad Genetics price target lowered to $8.50 from $9 at Piper Sandler
5M ago
Myriad Genetics adds 15 clinically actionable genes to MyRisk test
Premium
The Fly
Myriad Genetics adds 15 clinically actionable genes to MyRisk test
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100